MIAT and breast cancer: The data indicated an important role of the ER stress-mediated GRP78/OCT4/lncRNA MIAT/AKT pathway in cell resistance to 5-FU, highlighting potential molecular targets for combating 5-FU resistance in breast cancer [46].